En vivo
Lonza NewsAcetylacetone Market: Asia Dominates with Lonza, Daicel, Wacker Boosting Specialty Chemicals Demand - openPR.comThermo FisherThermo Fisher (TMO) Reports Q1: Everything You Need To Know Ahead Of Earnings - StockStory10x Genomics Blog10x Genomics: Atera Platform Launch Advances Spatial Biology With Single-Cell Resolution At Scale - Pulse 2.0Lonza NewsSimulations Plus partners with Lonza and FDA on drug formulation research - Investing.com AustraliaIlluminaCSR News Feed | Explore the latest corporate social responsibility news from Illumina - IlluminaFierceBiotechAACR: Revolution sees pancreatic cancer win as 'tip of the iceberg' as RAS wave risesFierceBiotechRacing toward first FDA nod for autoimmune CAR-T, Kyverna bolsters lead with full SPS datasetFierceBiotechRoche unpacks death imbalance, secondary endpoints in phase 3 multiple sclerosis trialsRoche MediaRoche unpacks death imbalance, secondary endpoints in phase 3 multiple sclerosis trials - Fierce BiotechLonza NewsProject Hope Foundation receives $50K donation from Lonza Capsugel - Greenville JournalHarvard BioscienceHarvard Bioscience (HBIO) 2026 proxy details director elections and equity plans - Stock TitanFierceBiotechPulnovo Medical scores $100M in finance round led by Medtronic
FierceBiotech 17 feb 2026

Compass guides psychedelic therapy to 2nd pivotal depression win, triggering approval push

Compass guides psychedelic therapy to 2nd pivotal depression win, triggering approval push

Original
Contenido no disponible. Consulta la fuente original.